# US 2003/0224443 A1 · Novel epithelial tissue imaging agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0224443 A1
- Document ID: US20030224443A1
- Status: Published application
- Kind: A1
- Application number: 10/062,467
- Filed: 2002-02-05
- Published: 2003-12-04
- Earliest claimed: 1997-01-10
- Assignees: Epicyte Pharmaceutical, Inc.
- Inventors: Andrew C. Hiatt; Mich B. Hein; John H. Fitchen
- Web page: https://patentgrep.com/patent/US20030224443A1

## CPC

- A61K 51/10: Antibodies or immunoglobulins; Fragments thereof {, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody}
- A61K 39/395: Antibodies (agglutinins A61K38/36 {; as drug carriers A61K47/50}); Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 2317/77: Internalization into the cell
- Y10S 530/81: Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Targeting molecules are provided for use in delivering imaging agents to epithelial tissue. The targeting molecule comprises a polypeptide that forms a closed covalent loop, contains at least three peptide domains having β-sheet character, each of the domains being separated by domains lacking β-sheet character. The targeting molecule specifically binds to a basolateral factor attached to a basolateral domain of an epithelial cell surface causing internalization of a linked imaging agent into the cells. The polypeptide or imaging agent may be linked to a peptide amino acid sequence that directs delivery of the imaging agent to a carcinoma cell, a nucleus, or an endoplasmic reticulum.

## Claims

### Claim 1

A targeting molecule capable of specifically binding to a basolateral factor associated with an epithelial surface and causing the internalization of an imaging agent linked thereto, wherein the targeting molecule is not full length dimeric IgA.

### Claim 2

A targeting molecule linked to at least one imaging agent, wherein said targeting molecule comprises a polypeptide that:
(a) forms a closed covalent loop; and
(b) contains at least three peptide domains having β-sheet character, each of the domains being separated by domains lacking β-sheet character;
wherein said targeting molecule is linked to at least one imaging agent by a substrate for an intracellular or extracellular enzyme associated with an epithelial barrier.

### Claim 3 (depends on 2)

A targeting molecule according to claim 2, wherein said enzyme is selected from the group consisting of proteases, glycosidases, phospholipases, esterases, hydrolases and nucleases.

### Claim 4

A targeting molecule linked to at least one imaging agent, wherein said targeting molecule comprises a polypeptide that:
(a) forms a closed covalent loop; and
(b) contains at least three peptide domains having β-sheet character, each of the domains being separated by domains lacking β-sheet character;
wherein said targeting molecule is linked to at least one imaging agent through a side chain of amino acids in an antibody combining site.

### Claim 5

A targeting molecule linked to at least one imaging agent, wherein said targeting molecule comprises a polypeptide that:
(a) forms a closed covalent loop; and
(b) contains at least three peptide domains having β-sheet character, each of the domains being separated by domains lacking β-sheet character;
wherein the imaging agent is not naturally associated with the targeting molecule, and wherein the imaging agent is not iodine.

### Claim 6 (depends on 5)

A targeting molecule according to claim 5, wherein said imaging agent is selected from the group consisting of metals, radioactive isotopes, radioopaque agents, radiolucent agents, contrast agents, dyes and enzymes.
